S&P 500   3,862.12 (+0.18%)
DOW   31,093.02 (+0.43%)
QQQ   328.95 (+0.26%)
AAPL   143.94 (+0.71%)
MSFT   232.39 (+1.25%)
FB   278.85 (+0.30%)
GOOGL   1,895.22 (+0.05%)
AMZN   3,305.77 (+0.36%)
TSLA   887.73 (+0.79%)
NVDA   544.41 (-0.31%)
BABA   265.08 (+1.42%)
CGC   33.83 (+2.80%)
GE   12.15 (+10.56%)
MU   81.14 (-0.17%)
AMD   94.13 (+0.00%)
NIO   60.03 (+0.07%)
T   29.12 (+0.03%)
F   11.37 (+0.71%)
ACB   10.30 (+1.38%)
BA   207.39 (+1.98%)
DIS   172.26 (+0.22%)
NFLX   559.87 (+0.55%)
GILD   68.12 (-0.06%)
S&P 500   3,862.12 (+0.18%)
DOW   31,093.02 (+0.43%)
QQQ   328.95 (+0.26%)
AAPL   143.94 (+0.71%)
MSFT   232.39 (+1.25%)
FB   278.85 (+0.30%)
GOOGL   1,895.22 (+0.05%)
AMZN   3,305.77 (+0.36%)
TSLA   887.73 (+0.79%)
NVDA   544.41 (-0.31%)
BABA   265.08 (+1.42%)
CGC   33.83 (+2.80%)
GE   12.15 (+10.56%)
MU   81.14 (-0.17%)
AMD   94.13 (+0.00%)
NIO   60.03 (+0.07%)
T   29.12 (+0.03%)
F   11.37 (+0.71%)
ACB   10.30 (+1.38%)
BA   207.39 (+1.98%)
DIS   172.26 (+0.22%)
NFLX   559.87 (+0.55%)
GILD   68.12 (-0.06%)
S&P 500   3,862.12 (+0.18%)
DOW   31,093.02 (+0.43%)
QQQ   328.95 (+0.26%)
AAPL   143.94 (+0.71%)
MSFT   232.39 (+1.25%)
FB   278.85 (+0.30%)
GOOGL   1,895.22 (+0.05%)
AMZN   3,305.77 (+0.36%)
TSLA   887.73 (+0.79%)
NVDA   544.41 (-0.31%)
BABA   265.08 (+1.42%)
CGC   33.83 (+2.80%)
GE   12.15 (+10.56%)
MU   81.14 (-0.17%)
AMD   94.13 (+0.00%)
NIO   60.03 (+0.07%)
T   29.12 (+0.03%)
F   11.37 (+0.71%)
ACB   10.30 (+1.38%)
BA   207.39 (+1.98%)
DIS   172.26 (+0.22%)
NFLX   559.87 (+0.55%)
GILD   68.12 (-0.06%)
S&P 500   3,862.12 (+0.18%)
DOW   31,093.02 (+0.43%)
QQQ   328.95 (+0.26%)
AAPL   143.94 (+0.71%)
MSFT   232.39 (+1.25%)
FB   278.85 (+0.30%)
GOOGL   1,895.22 (+0.05%)
AMZN   3,305.77 (+0.36%)
TSLA   887.73 (+0.79%)
NVDA   544.41 (-0.31%)
BABA   265.08 (+1.42%)
CGC   33.83 (+2.80%)
GE   12.15 (+10.56%)
MU   81.14 (-0.17%)
AMD   94.13 (+0.00%)
NIO   60.03 (+0.07%)
T   29.12 (+0.03%)
F   11.37 (+0.71%)
ACB   10.30 (+1.38%)
BA   207.39 (+1.98%)
DIS   172.26 (+0.22%)
NFLX   559.87 (+0.55%)
GILD   68.12 (-0.06%)
Log in
CVE:EBN

Epicore BioNetworks Inc. (EBN.V) Stock Forecast, Price & News

C$1.29
-0.01 (-0.77 %)
(As of 12/14/2017)
Add
Today's Range
C$1.29
Now: C$1.29
C$1.29
50-Day Range
C$1.29
MA: C$1.29
C$1.29
52-Week Range
C$0.54
Now: C$1.29
C$1.32
Volume54,778 shs
Average Volume29,654 shs
Market CapitalizationC$34.03 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Epicore BioNetworks Inc. (Epicore) develops, manufactures and markets specialty biotechnology, biochemical and nutrition products. Epicore specialty biochemical products are mixtures of specialty organic, inorganic and biochemical ingredients that facilitate microbe and plant growth. Some Epicore products (such as its EPIZYM-AGP COMPLETE) stimulate algae growth, an important property in shrimp and bivalve hatcheries that grow algae as animal food. Some of its products (such as EPIZYM-BGM) support microbe growth for customers who grow-up an Epicore microbial ecosystem at their location. Some Epicore biochemical products stimulate plant growth to increase plant yield and environmental stress resistance. The third Epicore product group is specialty animal feeds. These products are an extension of its microbial growth media expertise and are primarily used in aquaculture. Its EPIFEED -LHF and EPILITE liquid shrimp larval feeds are tools to help hatchery managers raise postlarval shrimp.

MarketRank

Overall MarketRank

0.52 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+1-609-2679118
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market CapC$34.03 million
Next Earnings DateN/A
OptionableNot Optionable
C$1.29
-0.01 (-0.77 %)
(As of 12/14/2017)
30 days | 90 days | 365 days | Advanced Chart

Receive EBN News and Ratings via Email

Sign-up to receive the latest news and ratings for EBN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Epicore BioNetworks Inc. (EBN.V) (CVE:EBN) Frequently Asked Questions

What stocks does MarketBeat like better than Epicore BioNetworks Inc. (EBN.V)?

Wall Street analysts have given Epicore BioNetworks Inc. (EBN.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Epicore BioNetworks Inc. (EBN.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What other stocks do shareholders of Epicore BioNetworks Inc. (EBN.V) own?

Who are Epicore BioNetworks Inc. (EBN.V)'s key executives?

Epicore BioNetworks Inc. (EBN.V)'s management team includes the following people:
  • William P. Long, President, Chief Executive Officer, Chief Operating Officer, Director
  • Russell Rosenzweig, Chief Financial Officer, Company Secretary
  • Robert Stephen Poulton, Non-Executive Chairman of the Board
  • Donald R. Siemens, Director
  • Stefan Zaphiriou Zarifi, Director
  • Alan C. Savage, Independent Director

What is Epicore BioNetworks Inc. (EBN.V)'s stock symbol?

Epicore BioNetworks Inc. (EBN.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EBN."

How do I buy shares of Epicore BioNetworks Inc. (EBN.V)?

Shares of EBN and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Epicore BioNetworks Inc. (EBN.V)'s stock price today?

One share of EBN stock can currently be purchased for approximately C$1.29.

How big of a company is Epicore BioNetworks Inc. (EBN.V)?

Epicore BioNetworks Inc. (EBN.V) has a market capitalization of C$34.03 million.

What is Epicore BioNetworks Inc. (EBN.V)'s official website?

The official website for Epicore BioNetworks Inc. (EBN.V) is epicorebionetworks.com.

How can I contact Epicore BioNetworks Inc. (EBN.V)?

Epicore BioNetworks Inc. (EBN.V)'s mailing address is 4 Lina Ln, EASTAMPTON, NJ 08060-5414, United States. The company can be reached via phone at +1-609-2679118.

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.